Skip to main content
LLY
NYSE Life Sciences

Boehringer-Zealand Obesity Drug Shows Strong Data: Up to 63% Liver Fat Reduction, Preserves Lean Mass

Tom Rudovsky · Reported by Reuters
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Neutral
Importance info
8
Price
$1,123
Mkt Cap
$1.066T
52W Low
$623.78
52W High
$1,166.29
52W Position info
80% above low
Off High info
3.7% below high
Rel. Volume info
1.3× avg
Market data snapshot near publication time

LLY sits 80% above its 52-week low of $623.78.

Summary

Boehringer Ingelheim and Zealand Pharma's experimental obesity drug, survodutide, demonstrated strong late-stage trial results, showing up to a 34% reduction in visceral fat and a 63.1% reduction in liver fat, while preserving lean muscle mass. This news introduces a potentially differentiated competitor into the rapidly growing obesity drug market, where Eli Lilly is a major player with its recently approved Foundayo and other GLP-1 agonists. The ability to specifically target harmful fat and maintain lean mass could be a key commercial differentiator for survodutide, intensifying the competitive landscape for Eli Lilly's obesity franchise.

At the time of this announcement, LLY was trading at $1,123.00 on NYSE in the Life Sciences sector, with a market capitalization of approximately $1.1T. The 52-week trading range was $623.78 to $1,166.29. This news item was assessed with neutral market sentiment and an importance score of 8 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

LLY - Latest Insights

LLY
Nov 18, 2026, 3:04 PM EST
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $1,381.18
Real-time Price: $1,353.23 info
Change: -$27.95 (-2%) info
Market Cap: $1.271T info
LLY
Nov 17, 2026, 11:18 AM EST
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $1,416.23
Real-time Price: $1,353.23 info
Change: -$63.00 (-4%) info
Market Cap: $1.271T info
LLY
Nov 16, 2026, 6:52 AM EST
Source: Reuters
Importance Score:
7
Price at Filing: $1,455.36
Real-time Price: $1,353.23 info
Change: -$102.13 (-7%) info
Market Cap: $1.271T info
LLY
Nov 12, 2026, 8:30 AM EST
Source: Benzinga
Importance Score:
7
Price at Filing: $1,452.70
Real-time Price: $1,353.23 info
Change: -$99.47 (-7%) info
Market Cap: $1.271T info
LLY
Nov 12, 2026, 3:00 AM EST
Source: Wiseek News
Importance Score:
8
Price at Filing: $1,447.85
Real-time Price: $1,353.23 info
Change: -$94.62 (-7%) info
Market Cap: $1.271T info